In a report released on October 27, Albin Sandberg from Kepler Capital maintained a Buy rating on Castellum (CTM – Research Report), with a price target of SEK130.00. The company’s shares closed last Friday at $0.36.
According to TipRanks, Sandberg is an analyst with an average return of -10.8% and a 34.14% success rate.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Castellum with a $11.66 average price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $1.98 and a one-year low of $0.18. Currently, Castellum has an average volume of 515.4K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Castellum (CTM) Company Description:
Castellum, Inc. is a biotech company, which engages in the development of water treatment and sanitization technologies. It focuses on acquiring and growing technology companies in the area of information technology. The company offers solutions to food, water and health industries. The company was founded by Jean Machetel Ekobo in September 2010 and is headquartered in Phoenix, AZ.
Read More on CTM:
